CRISPR Will Likely Not Solve Bird Flu
By Carol Cardona and Michelle Kromm,
Scientific American
| 03. 11. 2024
Recently, a group of scientists announced a breakthrough approach to combat Highly Pathogenic Avian Influenza (bird flu or avian flu), a severe illness of birds that has killed millions of chickens worldwide since it emerged in 1996 and continues to devastate bird populations. This disease has quickly become a potential threat to human health and has affected both food prices and availability.
Their approach uses a gene-editing technique called CRISPR/Cas9. In general, this method changes defined segments of an animal’s genetic code to functionally alter what that code does. In this case, CRISPR was used to alter chickens’ genetic code to make chickens more resistant to avian flu. While this was a fascinating use of the technology, any time scientific innovation affects the food we eat, it becomes a sensitive issue. On top of philosophical concerns regarding the use of CRISPR within our food supply, we think there are too many unpredictable outcomes related to combating avian influenza with CRISPR-modified chickens to expect this technology will be a solution to this destructive disease.
While CRISPR has created almost infinite opportunities...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...